TG Therapeutics Inc. (TGTX)
NASDAQ: TGTX
· Real-Time Price · USD
35.41
-0.58 (-1.61%)
At close: Jul 01, 2025, 3:59 PM
-1.61% (1D)
| Bid | 35.4 |
| Market Cap | 5.62B |
| Revenue (ttm) | 386.39M |
| Net Income (ttm) | 39.15M |
| EPS (ttm) | 0.25 |
| PE Ratio (ttm) | 141.66 |
| Forward PE | 20.56 |
| Analyst | Buy |
| Ask | 36.2 |
| Volume | 1,286,718 |
| Avg. Volume (20D) | 2,492,344 |
| Open | 35.74 |
| Previous Close | 35.99 |
| Day's Range | 35.10 - 36.91 |
| 52-Week Range | 16.65 - 46.48 |
| Beta | 1.94 |
About TGTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TGTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TGTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
TG Therapeutics Inc. is scheduled to release its earnings on Aug 5, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-13.26%
TG Therapeutics shares are trading lower after the...
Unlock content with
Pro Subscription
4 months ago
+14.39%
TG Therapeutics shares are trading higher after the company reported better-than-expected Q4 sales results.
